1. Home
  2. RSSS vs COEP Comparison

RSSS vs COEP Comparison

Compare RSSS & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Research Solutions Inc

RSSS

Research Solutions Inc

HOLD

Current Price

$2.29

Market Cap

86.5M

ML Signal

HOLD

Logo Coeptis Therapeutics Holdings Inc.

COEP

Coeptis Therapeutics Holdings Inc.

HOLD

Current Price

$16.40

Market Cap

91.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RSSS
COEP
Founded
2006
2017
Country
United States
United States
Employees
N/A
6
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
86.5M
91.2M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
RSSS
COEP
Price
$2.29
$16.40
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
99.4K
92.3K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
130.77
N/A
EPS
0.07
N/A
Revenue
$28,793,922.00
N/A
Revenue This Year
$1.81
N/A
Revenue Next Year
$5.73
N/A
P/E Ratio
$32.60
N/A
Revenue Growth
2.77
N/A
52 Week Low
$2.00
$6.80
52 Week High
$4.12
$21.41

Technical Indicators

Market Signals
Indicator
RSSS
COEP
Relative Strength Index (RSI) 44.26 72.18
Support Level $2.16 $13.77
Resistance Level $2.66 $19.19
Average True Range (ATR) 0.15 1.15
MACD -0.03 0.47
Stochastic Oscillator 38.67 87.62

Price Performance

Historical Comparison
RSSS
COEP

About RSSS Research Solutions Inc

Research Solutions Inc is a holding company. The company provides vertical software-as-a-service ("SaaS") and artificial intelligence ("AI") solutions, providing software and related services to help research-intensive organizations simplify the research process, save time, and money. The company operates in a single segment, which derives its revenue from subscription fees from its cloud-based SaaS Platforms and transactional service fees for the electronic delivery of single articles. The company generates the majority of its revenue from the Transactions. Geographically, the company generates the majority of its revenue from the United States, followed by Europe.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment.

Share on Social Networks: